CD4+ T cells have important roles against cancer in inducing and maintaining tumor-destructive immune responses.26 In this study, CD4+ T cells in spleen were increased from day 14–28 in the treated mice (Figure 2b), and similar results were also observed in the lung and peripheral blood (Supplementary Figures 2c and d). This evidence concerns the gene CD4 and neoplasm.